Company Filing History:
1 out of 2,885 
1 out of 1,187 
Years Active: 2019
Title: Innovations of Natasha Lucki
Introduction
Natasha Lucki is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cancer research through her innovative work on small molecule inhibitors.
Latest Patents
Natasha Lucki holds a patent for a "Small molecule inhibitor of 3-phosphoglycerate dehydrogenase and uses thereof." This invention focuses on small molecule inhibitors of PHGDH, which are crucial for developing methods to treat cancers. Additionally, her work includes methods for studying serine metabolism using these inhibitors.
Career Highlights
Throughout her career, Natasha has worked with esteemed institutions such as Cornell University and The Scripps Research Institute. Her research has been instrumental in advancing our understanding of cancer treatment.
Collaborations
Natasha has collaborated with notable scientists, including Lewis C. Cantley and Edouard Mullarky, enhancing the impact of her research through shared expertise.
Conclusion
Natasha Lucki's innovative contributions to cancer research and her patent on small molecule inhibitors highlight her role as a leading inventor in her field. Her work continues to pave the way for new treatment methods and a deeper understanding of cancer biology.